- /
- Supported exchanges
- / US
- / RPID.NASDAQ
Rapid Micro Biosystems Inc (RPID NASDAQ) stock market data APIs
Rapid Micro Biosystems Inc Financial Data Overview
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Rapid Micro Biosystems Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Rapid Micro Biosystems Inc data using free add-ons & libraries
Get Rapid Micro Biosystems Inc Fundamental Data
Rapid Micro Biosystems Inc Fundamental data includes:
- Net Revenue: 30 523 K
- EBITDA: -42 479 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-07
- EPS/Forecast: -0.25
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rapid Micro Biosystems Inc News
New
After-Hours Biotech Rally: SXTC, RPID, TGTX Lead Gains On Revenue Updates, And FDA Milestones
(RTTNews) - Several biotechnology and pharmaceutical names posted notable gains in Tuesday's after-hours trading session, driven by corporate updates and investor enthusiasm around clinical and financ...
Rapid Micro Biosystems reports Preliminary Q4 results
* Rapid Micro Biosystems press release [https://seekingalpha.com/pr/20363379-rapid-micro-biosystems-announces-record-preliminary-unaudited-fourth-quarter-and-full-year] (RPID [https://seekingalpha.c...
Rapid Micro Biosystems reports preliminary fourth quarter revenue
* Rapid Micro Biosystems (RPID [https://seekingalpha.com/symbol/RPID]) on Tuesday said that it expects preliminary unaudited fourth-quarter 2025 revenue of about $11.3 million, up roughly 37% from a...
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automat...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.